BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28542188)

  • 1. HSP90 inhibitors potentiate PGF2α-induced IL-6 synthesis via p38 MAP kinase in osteoblasts.
    Fujita K; Tokuda H; Kuroyanagi G; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
    PLoS One; 2017; 12(5):e0177878. PubMed ID: 28542188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSP90 inhibitors strengthen extracellular ATP-stimulated synthesis of interleukin-6 in osteoblasts: Amplification of p38 MAP kinase.
    Hioki T; Tokuda H; Nakashima D; Fujita K; Kawabata T; Sakai G; Kim W; Tachi J; Tanabe K; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
    Cell Biochem Funct; 2021 Jan; 39(1):88-97. PubMed ID: 32567086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Rho-kinase in prostaglandin F2alpha-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
    Minamitani C; Otsuka T; Takai S; Matsushima-Nishiwaki R; Adachi S; Hanai Y; Mizutani J; Tokuda H; Kozawa O
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):27-32. PubMed ID: 18586382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-kinase regulates thrombin-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
    Kato K; Otsuka T; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
    Int J Mol Med; 2011 Oct; 28(4):653-8. PubMed ID: 21750859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSP90 inhibitors diminish PDGF-BB-induced migration of osteoblasts via suppression of p44/p42 MAP kinase.
    Kawabata T; Tokuda H; Fujita K; Matsushima-Nishiwaki R; Sakai G; Tachi J; Hioki T; Kim W; Iida H; Otsuka T; Kozawa O
    Biomed Res; 2019; 40(4):169-178. PubMed ID: 31413238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement by HSP90 inhibitor of PGD2-stimulated HSP27 induction in osteoblasts: Suppression of SAPK/JNK and p38 MAP kinase.
    Kim W; Tokuda H; Kawabata T; Fujita K; Sakai G; Nakashima D; Tachi J; Kuroyanagi G; Matsushima-Nishiwaki R; Tanabe K; Otsuka T; Iida H; Kozawa O
    Prostaglandins Other Lipid Mediat; 2019 Aug; 143():106327. PubMed ID: 30946899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of Rho-kinase in prostaglandin D2-induced interleukin-6 synthesis in osteoblasts.
    Tokuda H; Takai S; Matsushima-Nishiwaki R; Hanai Y; Adachi S; Minamitani C; Mizutani J; Otsuka T; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):41-6. PubMed ID: 18771907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-kinase regulates endothelin-1-stimulated IL-6 synthesis via p38 MAP kinase in osteoblasts.
    Tokuda H; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Doi T; Harada A; Takai S; Kozawa O
    Biochem Biophys Res Commun; 2007 Nov; 362(4):799-804. PubMed ID: 17825250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSP90 inhibitors induce desensitization of EGF receptor via p38 MAPK-mediated phosphorylation at Ser1046/1047 in human pancreatic cancer cells.
    Adachi S; Yasuda I; Nakashima M; Yamauchi T; Yamauchi J; Natsume H; Moriwaki H; Kozawa O
    Oncol Rep; 2010 Jun; 23(6):1709-14. PubMed ID: 20428829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSP22 (HSPB8) positively regulates PGF2α-induced synthesis of interleukin-6 and vascular endothelial growth factor in osteoblasts.
    Kuroyanagi G; Sakai G; Otsuka T; Yamamoto N; Fujita K; Kawabata T; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    J Orthop Surg Res; 2021 Jan; 16(1):72. PubMed ID: 33478532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation by HSP90 inhibitors of EGF-elicited migration of osteoblasts: involvement of p44/p42 MAP kinase.
    Kuroyanagi G; Kawabata T; Tokuda H; Fujita K; Matsushima-Nishiwaki R; Sakai G; Tachi J; Hioki T; Kim W; Iida H; Otsuka T; Kozawa O
    Connect Tissue Res; 2022 Jul; 63(4):359-369. PubMed ID: 34100663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incretins Enhance PGF2α-Induced Synthesis of IL-6 and Osteoprotegerin in Osteoblasts.
    Hioki T; Kuroyanagi G; Fujita K; Sakai G; Kawabata T; Kim W; Tachi J; Matsushima-Nishiwaki R; Iida H; Kozawa O; Tokuda H
    Horm Metab Res; 2022 Jan; 54(1):42-49. PubMed ID: 34986499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts.
    Kondo A; Otsuka T; Kato K; Natsume H; Kuroyanagi G; Mizutani J; Ito Y; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Int J Mol Med; 2012 Dec; 30(6):1487-92. PubMed ID: 23064268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho-kinase limits FGF-2-stimulated VEGF release in osteoblasts.
    Natsume H; Tokuda H; Adachi S; Takai S; Matsushima-Nishiwaki R; Kato K; Minamitani C; Niida S; Mizutani J; Kozawa O; Otsuka T
    Bone; 2010 Apr; 46(4):1068-74. PubMed ID: 20114091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt3a upregulates prostaglandin F2α-stimulated vascular endothelial growth factor synthesis in osteoblasts.
    Kondo A; Tokuda H; Mizutani J; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
    Mol Med Rep; 2012 Aug; 6(2):421-5. PubMed ID: 22614766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
    Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
    Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of heat shock protein 90 augment endothelin‑1‑induced heat shock protein 27 through the SAPK/JNK signaling pathway in osteoblasts.
    Fujita K; Otsuka T; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Mol Med Rep; 2018 Jun; 17(6):8542-8547. PubMed ID: 29658585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of TGF-β-induced HSP27 by HSP90 inhibitors in osteoblasts.
    Kuroyanagi G; Tokuda H; Fujita K; Kawabata T; Sakai G; Kim W; Hioki T; Tachi J; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
    BMC Musculoskelet Disord; 2022 May; 23(1):495. PubMed ID: 35619094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho-kinase limits BMP-4-stimulated osteocalcin synthesis in osteoblasts: regulation of the p38 MAP kinase pathway.
    Kondo A; Tokuda H; Matsushima-Nishiwaki R; Kuroyanagi G; Yamamoto N; Mizutani J; Kozawa O; Otsuka T
    Life Sci; 2014 Feb; 96(1-2):18-25. PubMed ID: 24368139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor-BB amplifies PGF2alpha-stimulated VEGF synthesis in osteoblasts: function of phosphatidylinositol 3-kinase.
    Tokuda H; Takai S; Hanai Y; Harada A; Matsushima-Nishiwaki R; Akamatsu S; Ohta T; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):187-93. PubMed ID: 17980568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.